iSOFT Wins 2010 European Business Analytics Systems Competitive Strategy Leadership Award

iSOFTiSOFT Group Limited, one of the world's largest healthcare information technology companies, has received the Frost and Sullivan, 2010 European Business Analytics Systems Competitive Strategy Leadership Award.

HiNT is a powerful business analytics tool designed to empower modern healthcare organisations with business-critical information. By consolidating data from all the various applications within an organisation, users can view and explore information, trends and performance indicators covering all aspects of service delivery and financial performance. Designed around the latest clinical coding standards and with prebuilt reporting dashboards covering clinical activity, administration, finance and performance, Health Intelligence was seen as the market leader by Frost & Sullivan, and the clear winner for this award.

For the Competitive Strategy Leadership Award, the following criteria were used to benchmark iSOFT's performance against key competitors:

  • Leverage of competitive intelligence
  • Execution of competitive strategy
  • Impact on market share
  • Competitive brand positioning (brand strength and unique market position)
  • Impact on customer satisfaction/value

Through the overall product strategy, management and marketing, this award recognises iSOFT's growing market share and ongoing commitment to the healthcare sector.

The award was presented to Eamonn Morris, Managing Director of iSOFT Business Solutions, at a gala awards dinner in London on 19 May. Eamonn Morris said: "This is a significant achievement for iSOFT and illustrates the power and uniqueness of the iSOFT Health Intelligence solution, HiNT. Since taking the solution to market in late 2009, we have seen a huge interest from clients, prospects and partners in all territories across the globe. At iSOFT we have a dream, which is enhancing lives through innovative healthcare solutions; HiNT is a prime example of where iSOFT have designed and developed a solution which will add value to healthcare organisations worldwide, providing administrative, financial and clinical intelligence to enable informed decisions regarding the management and delivery of healthcare."

Frost & Sullivan acknowledges iSOFT's significant investments in research and development to improve the organisation's position, commenting, "iSOFT places more emphasis on providing user-friendly and efficient information and analytic solutions for its healthcare customers. Hundreds of hospitals have adopted iSOFT's healthcare information systems, as they offer greater return on investment."

A global network of iSOFT subsidiaries and partner networks provides significant support to the national healthcare markets, offering customers a complete suite of solutions and services around the world.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organizations.

Today, more than 13,000 provider organizations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

About Frost and Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit www.frost.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...